Frontotemporal dementia trials in Canada
6 of 13 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Taking peopleTrial of ARO-MAPT-SC in Healthy Participants and Participants With Early Alzheimer's Disease or Primary Tauopathies
- Where
- East York, Montreal, Toronto
- Age
- 18 years and over
- People
- 160 worldwide
- Run by
- Arrowhead Pharmaceuticals
See details and how to joinNCT07221344 - No phaseTaking peopleEffects of Probiotics in Amyotrophic Lateral Sclerosis-Frontotemporal Dementia Spectrum Disorder (ALS-FTDSD) Patients
- Where
- Fredericton, Montreal, Saskatoon
- Age
- 18 years and over
- People
- 150
- Run by
- Centre hospitalier de l'Université de Montréal (CHUM)
See details and how to joinNCT06051123 - Phase 1/2Taking peopleA Study to Evaluate the Safety and Effect of AVB-101, a Gene Therapy Product, in Subjects With a Genetic Sub-type of Frontotemporal Dementia (FTD-GRN)
- Where
- Toronto
- Age
- 30 years to 75 years
- People
- 18 worldwide
- Run by
- AviadoBio Ltd
See details and how to joinNCT06064890 · EU 2023-509444-10-00 - Phase 2Taking peopleTranscranial Direct Current Stimulation in the Treatment of Primary Progressive Aphasia
- Where
- Toronto
- Age
- 50 years to 90 years
- People
- 180 worldwide
- Run by
- Johns Hopkins University
See details and how to joinNCT05386394 - No phaseTaking peopleMolecular Neuroimaging of Neuroinflammation in Neurodegenerative Dementias
- Where
- London
- Age
- 30 years to 95 years
- People
- 40
- Run by
- London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
See details and how to joinNCT02945774 - Phase 4Taking peopleLemborexant for Insomnia in a Patient With Dementia: An N-of-1 Trial
- Where
- Halifax
- People
- 1
- Run by
- Nova Scotia Health Authority
See details and how to joinNCT06093126